Author:
Bloomfield Michael AP,Pepper Fiona,Egerton Alice,Demjaha Arsime,Tomasi Gianpaolo,Mouchlianitis Elias,Maximen Levi,Veronese Mattia,Turkheimer Federico,Selvaraj Sudhakar,Howes Oliver D
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Pharmacology
Reference61 articles.
1. Balfour DJ, Wright AE, Benwell ME, Birrell CE (2000). The putative role of extra-synaptic mesolimbic dopamine in the neurobiology of nicotine dependence. Behav Brain Res 113: 73–83.
2. Barkus EJ, Stirling J, Hopkins RS, Lewis S (2006). Cannabis-induced psychosis-like experiences are associated with high schizotypy. Psychopathology 39: 175–178.
3. Barrett SP, Boileau I, Okker J, Pihl RO, Dagher A (2004). The hedonic response to cigarette smoking is proportional to dopamine release in the human striatum as measured by positron emission tomography and [11C]raclopride. Synapse 54: 65–71.
4. Benowitz NL, Henningfield JE (1994). Establishing a nicotine threshold for addiction. The implications for tobacco regulation. N Engl J Med 331: 123–125.
5. Benowitz NL, Jacob P 3rd, Jones RT, Rosenberg J (1982). Interindividual variability in the metabolism and cardiovascular effects of nicotine in man. J Pharmacol Exp Ther 221: 368–372.